AMS Capital’s BioTelemetry, Inc. BEAT Stock Holding History

AMS Capital’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,775	Closed	-$630K	–	53
2018 Q3	$630K	Buy	+9,775	New	+$545K	0.52%	38

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AMS Capital's BEAT Position: Q4 2018 in Review

AMS Capital sold out of BioTelemetry, Inc. (BEAT) in Q4 2018, closing a stake of 9,775 shares — an estimated $630K sold.

AMS Capital first reported a position in BEAT in Q3 2018 and held it in 1 quarter. The position peaked at $630K in Q3 2018. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

AMS Capital reported no remaining BioTelemetry, Inc. position as of Q4 2018 after selling out during the quarter.
AMS Capital sold 9,775 BioTelemetry, Inc. shares in Q4 2018, an estimated $630K.
AMS Capital first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 1 quarter.
AMS Capital's BioTelemetry, Inc. position peaked at $630K in Q3 2018.
281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on AMS Capital's 13F filing for Q4 2018, filed 29 Jan 2019.